Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis. | Zendy

Gary R. Sitko | Zendy; Denise Ramjit | Zendy; Inez I. Stabilito | Zendy; Dale Lehman | Zendy; Joseph J. Lynch | Zendy; G P Vlasuk | Zendy

Open Access

Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.

Author(s) -

Gary R. Sitko,

Denise Ramjit,

Inez I. Stabilito,

Dale Lehman,

Joseph J. Lynch,

G P Vlasuk

Publication year - 1992

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.85.2.805

Subject(s) - medicine , heparin , thrombolysis , antithrombotic , bolus (digestion) , hirudin , plasminogen activator , anesthesia , pharmacology , cardiology , platelet , thrombin , myocardial infarction

Effective thrombolytic recanalization of an occluded coronary vessel is often limited by acute thrombotic reocclusion, which has galvanized the search for effective adjunctive or conjunctive antithrombotic agents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research